{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:11:22Z","timestamp":1760955082211},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,10,23]],"date-time":"2008-10-23T00:00:00Z","timestamp":1224720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s10067-008-1026-6","type":"journal-article","created":{"date-parts":[[2008,10,22]],"date-time":"2008-10-22T07:28:57Z","timestamp":1224660537000},"page":"89-92","source":"Crossref","is-referenced-by-count":12,"title":["Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study"],"prefix":"10.1007","volume":"28","author":[{"given":"Salvatore","family":"Corrao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Pistone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Colomba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Licata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,23]]},"reference":[{"issue":"suppl 20","key":"1026_CR1","first-page":"S9","volume":"18","author":"MA Cimmino","year":"2000","unstructured":"Cimmino MA, Zaccaria A (2000) Epidemiology of polymyalgia rheumatica. Clin Exp Rheumatol 18(suppl 20):S9\u2013S11","journal-title":"Clin Exp Rheumatol"},{"key":"1026_CR2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(97)05001-0","volume":"350","author":"C Salvarani","year":"1997","unstructured":"Salvarani C, Macchioni P, Bioardi L (1997) Polymyalgia rheumatica. Lancet 350:43\u201347","journal-title":"Lancet"},{"key":"1026_CR3","first-page":"138","volume":"3","author":"V Kyle","year":"1997","unstructured":"Kyle V (1997) Polymyalgia reumatica. Prescribers\u2019 J 3:138\u2013144","journal-title":"Prescribers\u2019 J"},{"key":"1026_CR4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","volume":"97","author":"T Chuang","year":"1982","unstructured":"Chuang T, Hunder GG, Ilstrup DM, Kurland LT (1982) Polymyalgia rheumatica\u2014a 10\u00a0year epidemiological and clinical study. Ann Intern Med 97:672\u2013680","journal-title":"Ann Intern Med"},{"key":"1026_CR5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/ard.53.5.331","volume":"53","author":"MA Cimmino","year":"1994","unstructured":"Cimmino MA, Moggiana G, Montecucco C, Caporali R, Accardo S (1994) Long term treatment of polymyalgia rheumatica with deflazacort. Ann Rheum Dis 53:331\u2013333","journal-title":"Ann Rheum Dis"},{"key":"1026_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/03009749950155445","volume":"28","author":"JT Gran","year":"1999","unstructured":"Gran JT (1999) Current therapy of polymyalgia rheumatica [editorial]. Scand J Rheumatol 28:269\u2013272","journal-title":"Scand J Rheumatol"},{"key":"1026_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","volume":"347","author":"C Salvarani","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347:261\u2013271","journal-title":"N Engl J Med"},{"key":"1026_CR8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.58.5.303","volume":"58","author":"C Salvarani","year":"1999","unstructured":"Salvarani C, Boiardi L, Mantovani V, Ranzi A, Cantini F, Olivieri I et al (1999) HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity. Ann Rheum Dis 58:303\u2013308","journal-title":"Ann Rheum Dis"},{"key":"1026_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","volume":"134","author":"JA Jover","year":"2001","unstructured":"Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B (2001) Combined treatment of giant-cell arteritis with methotrexate and prednisone. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 134:106\u2013114","journal-title":"Ann Intern Med"},{"key":"1026_CR10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","volume":"46","author":"GS Hoffman","year":"2002","unstructured":"Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J et al (2002) A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 46:1309\u20131318","journal-title":"Arthritis Rheum"},{"key":"1026_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","volume":"141","author":"R Caporali","year":"2004","unstructured":"Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C et al (2004) Prednisone plus methotrexate for polymyalgia rheumatica. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 141:493\u2013500","journal-title":"Ann Intern Med"},{"issue":"9","key":"1026_CR12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-146-9-200705010-00005","volume":"46","author":"C Salvarani","year":"2007","unstructured":"Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P et al (2007) Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 46(9):631\u2013639","journal-title":"Ann Intern Med"},{"key":"1026_CR13","unstructured":"The Oxford Centre for Evidence-based Medicine Levels of Evidence (2007) http:\/\/www.pdptoolkit.co.uk\/Files\/ebm\/indexes\/guide%20to%20ebm.htm Accessed July 2 2007"},{"issue":"8","key":"1026_CR14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/39.8.883","volume":"39","author":"S Kalke","year":"2000","unstructured":"Kalke S, Mukerjee D, Dasgupta B (2000) A study of the health assessment questionnaire to evaluate functional status in polymyalgia rheumatica. Rheumatology 39(8):883\u2013885","journal-title":"Rheumatology"},{"issue":"4","key":"1026_CR15","first-page":"760","volume":"30","author":"C Salvarani","year":"2003","unstructured":"Salvarani C, Cantini F, Niccoli L, Catanoso MG, Macchioni P, Pulsatelli L et al (2003) Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study. J Rheumatol 30(4):760\u2013763","journal-title":"J Rheumatol"},{"issue":"6","key":"1026_CR16","first-page":"373","volume":"9","author":"A Migliore","year":"2005","unstructured":"Migliore A, Massafra U, Carloni E, Padalino C, Martin Martin S, Lasaracina F et al (2005) TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and\/or osteoporosis: a seven cases report. Eur Rev Med Pharmacol Sci 9(6):373\u2013378","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"1026_CR17","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","volume":"26","author":"LS Tam","year":"2007","unstructured":"Tam LS, Tomlinson B, Chu TT, Li TK Li EK (2007) Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 26(9):1495\u20131498","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1026_CR18","first-page":"83","volume":"24","author":"MA Gonzalez-Gay","year":"2006","unstructured":"Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J (2006) Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 24(1):83\u201386","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"1026_CR19","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/dc06-0636","volume":"29","author":"B Yazdani-Biuki","year":"2006","unstructured":"Yazdani-Biuki B, Mueller T, Brezinschek HP, Hermann J, Graninger W, Wascher TC (2006) Relapse of diabetes after interruption of chronic administration of anti-tumor necrosis factor-alpha antibody infliximab: a case observation. Diabetes Care 29(7):1712\u20131713","journal-title":"Diabetes Care"},{"issue":"10","key":"1026_CR20","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1248\/bpb.29.2095","volume":"29","author":"T Adachi","year":"2006","unstructured":"Adachi T, Toishi T, Takashima E, Hara H (2006) Infliximab neutralizes the suppressive effect of TNF-alpha on expression of extracellular-superoxide dismutase in vitro. Biol Pharm Bull 29(10):2095\u20132098","journal-title":"Biol Pharm Bull"},{"issue":"9","key":"1026_CR21","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/1529-0131(200109)44:9<2160::AID-ART369>3.0.CO;2-0","volume":"44","author":"S Iyama","year":"2001","unstructured":"Iyama S, Okamoto T, Sato T, Yamauchi N, Sato Y, Sasaki K et al (2001) Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum 44(9):2160\u20132167","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1026_CR22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1677\/joe.0.1810413","volume":"181","author":"T Adachi","year":"2004","unstructured":"Adachi T, Inoue M, Hara H, Maehata E, Suzuki S (2004) Relationship of plasma extracellular-superoxide dismutase level with insulin resistance in type 2 diabetic patients. J Endocrinol 181(3):413\u2013417","journal-title":"J Endocrinol"},{"issue":"8","key":"1026_CR23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archinte.166.8.902","volume":"166","author":"LE Bernstein","year":"2006","unstructured":"Bernstein LE, Berry J, Kim S, Canavan B, Grinspoon SK (2006) Effects of etanercept in patients with the metabolic syndrome. Arch Intern Med 166(8):902\u2013908","journal-title":"Arch Intern Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-1026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-008-1026-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-008-1026-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:32Z","timestamp":1559119892000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-008-1026-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,23]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1007\/s10067-008-1026-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,23]]}}}